2021 Insights on Keratoconjunctivitis Drugs in Development - ResearchAndMarkets.com
The "Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering.
- The "Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering.
- The report provides comprehensive information on the therapeutics under development for Keratoconjunctivitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.
- Additionally, the report provides an overview of key players involved in therapeutic development for Keratoconjunctivitis and features dormant and discontinued projects.
- The report reviews key players involved in the development of Keratoconjunctivitis (Ophthalmology) therapeutics and enlists all their major and minor projects.